Research project
Optimizing MATrix as remission induction treatment for newly diagnosed primary CNS Lymphoma – a randomized phase III trial (OPTIMATE trial)
-
Research groups:
-
Lead researchers:
-
Other researchers:
-
Research funder:Cancer Research UK
-
Status:Active
